Literature DB >> 32828781

Imaging Interstitial Fibrosis, Left Ventricular Remodeling, and Function in Stage A and B Heart Failure.

Theo Pezel1, Magalie Viallon2, Pierre Croisille2, Laurent Sebbag3, Thomas Bochaton4, Jerome Garot5, Joao A C Lima6, Nathan Mewton7.   

Abstract

Myocardial interstitial fibrosis is part of the advanced disease stage of most cardiovascular pathologies. It has been characterized histologically in various disease settings from hypertensive heart disease and diabetic cardiomyopathy to severe aortic stenosis. It is also involved in the process of aging. In cardiovascular medicine, myocardial interstitial fibrosis is associated with several adverse outcomes, especially heart failure (HF) and sudden cardiac death. Until recently, clinical measures of interstitial fibrosis could only be made by invasive myocardial biopsy. The availability of cardiac magnetic resonance (CMR) T1 mapping techniques allows for the indirect measurement of interstitial space characteristics and extracellular volume size, which is closely correlated with collagen content and interstitial infiltration by amyloid and other molecules. There has been significant improvement in the accuracy and reproducibility of T1 acquisition sequences in the last decade; however, the correct use of this technique requires a solid CMR expertise in daily imaging practice. CMR has become the gold standard to assess left ventricular (LV) remodeling and functional features associated with interstitial fibrosis. These features can be detected in the early stages of HF. The main objective of this paper is to review the relevant results of preclinical and clinical observational studies that demonstrate the prognostic impact of interstitial fibrosis assessed by T1 mapping, as well as adverse left ventricular remodeling, as determinants of HF. Therefore, this review focuses on the pathological mechanisms underlying LV remodeling and interstitial fibrosis, in addition to the technical considerations involved in the assessment of interstitial LV fibrosis by CMR. It provides a thorough review of clinical evidence that demonstrates the association of interstitial fibrosis and other-CMR derived LV phenotypes with Stages A and B HF.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  T1 mapping; cardiovascular risk factors; heart failure; interstitial fibrosis; left ventricular remodeling

Year:  2020        PMID: 32828781     DOI: 10.1016/j.jcmg.2020.05.036

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  9 in total

1.  Cardiac fibrosis in oncologic therapies.

Authors:  René R Sevag Packard
Journal:  Curr Opin Physiol       Date:  2022-08-08

2.  Regional Strain Score as Prognostic Marker of Cardiovascular Events From the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Theo Pezel; David A Bluemke; Colin O Wu; João A C Lima; Bharath Ambale Venkatesh
Journal:  Front Cardiovasc Med       Date:  2022-05-13

3.  Left Atrioventricular Coupling Index to Predict Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Theo Pezel; Bharath Ambale Venkatesh; Yoko Kato; Henrique Doria De Vasconcellos; Susan R Heckbert; Colin O Wu; Wendy S Post; David A Bluemke; Alain Cohen-Solal; Patrick Henry; João A C Lima
Journal:  Front Cardiovasc Med       Date:  2021-09-01

4.  SGLT2 Inhibition in HFpEF. Do We Need More Quantitative and Load Independent Metrics to Understand the Results of the EMPEROR-Preserved Trial?

Authors:  Grigorios Korosoglou; Sorin Giusca; Sebastian Kelle
Journal:  Front Cardiovasc Med       Date:  2022-01-14

5.  Identification of reference genes for gene expression studies among different developmental stages of murine hearts.

Authors:  Jie Ren; Ningning Zhang; Xiangjie Li; Xiaogang Sun; Jiangping Song
Journal:  BMC Dev Biol       Date:  2021-09-08       Impact factor: 1.978

6.  SS31 Alleviates Pressure Overload-Induced Heart Failure Caused by Sirt3-Mediated Mitochondrial Fusion.

Authors:  Mengying Suo; Yan Qi; Lingxin Liu; Chunmei Zhang; Jingyuan Li; Xuefang Yan; Chen Zhang; Yun Ti; Tongshuai Chen; Peili Bu
Journal:  Front Cardiovasc Med       Date:  2022-05-03

7.  Tumstatin (69-88) alleviates heart failure via attenuating oxidative stress in rats with myocardial infarction.

Authors:  Congfei Zhu; Zhi Zuo; Cheng Xu; Mingyue Ji; Junjie He; Jinshuang Li
Journal:  Heliyon       Date:  2022-09-12

Review 8.  Protective Effect of Natural Medicinal Plants on Cardiomyocyte Injury in Heart Failure: Targeting the Dysregulation of Mitochondrial Homeostasis and Mitophagy.

Authors:  Qi Wang; Hao Su; Jinfeng Liu
Journal:  Oxid Med Cell Longev       Date:  2022-09-12       Impact factor: 7.310

9.  Guanxin V Acts as an Antioxidant in Ventricular Remodeling.

Authors:  Bo Liang; Rui Li; Yi Liang; Ning Gu
Journal:  Front Cardiovasc Med       Date:  2022-01-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.